XML 46 R29.htm IDEA: XBRL DOCUMENT
v3.19.3

FORMER COLLABORATION AGREEMENT (Details) |  |  |  |  | 9 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Jun. 14, 2019 USD ($) | Sep. 28, 2018 | Sep. 27, 2018 | Dec. 15, 2014 item | Sep. 30, 2019 USD ($) | Dec. 31, 2018 USD ($)
Former Collaborative Arrangement [Line Items] |  |  |  |  |  |
Percentage of costs to be paid by Geron after termination of Collaboration Agreement |  |  |  |  | 100.00% |
Amount due to Janssen Biotech, Inc. |  |  |  |  | $ 1,208,000 | $ 2,610,000
Former Collaboration Agreement |  |  |  |  |  |
Former Collaborative Arrangement [Line Items] |  |  |  |  |  |
Number of agreed upon studies | item |  |  |  | 2 |  |
Percentage of costs to be paid by Geron |  |  |  | 50.00% |  |
Percentage of costs to be paid by Janssen |  |  |  | 50.00% |  |
Percentage of costs to be paid by Geron before termination of Collaboration Agreement |  |  | 50.00% |  |  |
Percentage of costs to be paid by Geron after termination of Collaboration Agreement |  | 100.00% |  |  |  |
Amount due to Janssen Biotech, Inc. |  |  |  |  | $ 1,208,000 |
Clinical Supply Agreement |  |  |  |  |  |
Former Collaborative Arrangement [Line Items] |  |  |  |  |  |
Expected payment for drug product upon shipment | $ 7,500,000 |  |  |  |  |
Clinical Supply Agreement | Maximum |  |  |  |  |  |
Former Collaborative Arrangement [Line Items] |  |  |  |  |  |
Expected payment for drug substance and raw materials upon testing and confirmation | $ 6,700,000 |  |  |  |  |

X
- Definition Represents the percentage of costs that the company must pay after the termination of the Collaboration Agreement. + References No definition available. + Details
Name: | gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity
Namespace Prefix: | gern_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of costs that the company must pay before the termination of the Collaboration Agreement + References No definition available. + Details
Name: | gern_CollaborativeArrangementBeforeTerminationCostSharingPercentageOfEntity
Namespace Prefix: | gern_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of costs that Janssen must pay during certain phases of the agreement. + References No definition available. + Details
Name: | gern_CollaborativeArrangementCostSharingPercentageOfCounterparty
Namespace Prefix: | gern_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of costs that Geron must pay during certain phases of the agreement. + References No definition available. + Details
Name: | gern_CollaborativeArrangementCostSharingPercentageOfEntity
Namespace Prefix: | gern_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of agreed upon studies. + References No definition available. + Details
Name: | gern_CollaborativeArrangementNumberOfStudies
Namespace Prefix: | gern_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of obligations due to counterparty. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). + References No definition available. + Details
Name: | gern_DueToCounterParty
Namespace Prefix: | gern_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Expected payment for drug product upon shipment. + References No definition available. + Details
Name: | gern_ExpectedPaymentForDrugProductUponShipment
Namespace Prefix: | gern_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Expected payment for drug substance and raw materials upon testing and confirmation. + References No definition available. + Details
Name: | gern_ExpectedPaymentForDrugSubstanceAndRawMaterialsUponTestingAndConfirmation
Namespace Prefix: | gern_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Former collaborative arrangement. + References No definition available. + Details
Name: | gern_FormerCollaborativeArrangementLineItems
Namespace Prefix: | gern_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=gern_FormerCollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=gern_ClinicalSupplyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |